Adaptive Biotechnologies Corp - Common Stock, par value $0.0001 per share (ADPT)

CUSIP: 00650F109

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 7 signals
Share change
+1,238,479
Put/Call ratio
15%
SEC-reported price per share
$13.88
Number of holders
294
Value change
+$6,707,442
Number of buys
146
Open additional details 1 more signal available
Number of sells
132
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
159,541,000

Security key

00650F109

Report period

Q1 2026

Institutions

294

Top holders

10

Ownership snapshot

Top reported holders of ADPT - Adaptive Biotechnologies Corp - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VIKING GLOBAL INVESTORS LP
Disclosed value leader
VIKING GLOBAL INVESTORS LP
Comparable rows
15/15
Latest evidence
04 Mar 2026
13F 13D/G 3/4/5 Lead comparable stake: 19% 13D/G row: VIKING GLOBAL INVESTORS LP Showing 1-6 of 15 holder rows.

Quick read

VIKING GLOBAL INVESTORS LP leads the comparable SEC ownership view at 19%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VIKING GLOBAL INVESTORS LP's linked filing trail.
Comparable ownership Top 5
VIKING GLOBAL INVESTORS LP 19%
BlackRock, Inc. 7.9%
Amova Asset Management Americas, ... 4.6%
Sumitomo Mitsui Trust Group, Inc. 4.6%
INTEGRATED CORE STRATEGIES (US) LLC 4.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VIKING GLOBAL INVESTORS LP
13F 13D/G
Company
19%
from 13D/G
$487,097,818
29,993,708 shares
31 Dec 2025
BlackRock, Inc.
13F 13D/G
Company
7.9%
from 13D/G
$216,536,989
13,333,559 shares
31 Dec 2025
Amova Asset Management Americas, Inc.
13D/G 13F
Nikko Asset Management Americas, Inc. · Company
4.6%
$53,981,782
6,833,137 shares
$0 31 Dec 2024
Sumitomo Mitsui Trust Group, Inc.
13D/G 13F
Company
4.6%
$53,981,782
6,833,137 shares
$0 31 Dec 2024
INTEGRATED CORE STRATEGIES (US) LLC
13D/G
Millennium Management LLC
4.3%
$49,711,809
6,292,634 shares
$0 31 Dec 2024
Rubric Capital Management LP
13D/G
4.1%
$72,889,139
6,256,847 shares
$0 30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
294
Shares
151,849,504
Rows available
294
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders
294
Q1 2026 holders
294
Holder diff
0
Investor Q1 2026 Shares Q1 2026 Shares Share Diff Share Chg % Q1 2026 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .